Author

Mohammed A. Alnuhait

Observed names: Alnuhait, Mohammed A., Mohammed A Alnuhait, Mohammed Al Nuhait, Mohammed Alnuhait, Mohammed alnuhait

Institutions: Shaqra University, Saudi Food and Drug Authority

Observed institutions: Alfaisal University, Qassim University, King Saud bin Abdulaziz University for Health Sciences, Umm al-Qura University, Shaqra University, King Fahd Medical City, King Saud University, King Abdulaziz Medical City, King Fahd Armed Forces Hospital, Ministry of Health, King Abdullah Medical City, Saudi Food and Drug Authority, National Guard Health Affairs

ORCID: 0000-0002-5279-5437

Observed ORCID: 0000-0002-5279-5437

OpenAlex ID: A5018767717

The Perils of Methanol Exposure: Insights into Toxicity and Clinical Management

2024 · Mohammed Alrashed, Norah S. Aldeghaither, et al. · Toxics · 47

PDF

What Is the Current State of Awareness, Knowledge, and Attitudes Toward Breast Cancer? A Cross-Sectional Survey Among Health and Non-health College Students

2022 · Md. Ashraful Islam, Dhfer Mahdi AlShayban, et al. · Frontiers in Public Health · 26

PDF

Risk of Lichen Sclerosus and Lichen Planus in Patients Receiving Immune Checkpoint Inhibitors

2022 · Ahmad Alharbi, Attiah Khobrani, et al. · International Journal of Environmental Research and Public Health · 16

PDF

Humoral and Cellular Immunity following Five Doses of COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis

2023 · Abdulmalik S. Alotaibi, Heba A. Shalabi, et al. · Vaccines · 14

PDF

Trastuzumab Deruxtecan-Associated Interstitial Lung Disease: Real-World Insights from a Tertiary Care Center

2025 · Ahmed S. Alanazi, Ahmed A. Alanazi, et al. · Current Oncology · 11

PDF

Clinical Trial Awareness, Perceptions, and Participation Among Cancer Patients in Saudi Arabia

2025 · Maryam Alotaibi, Laila Alsolami, et al. · Healthcare · 11

PDF

Advancing cancer care: How artificial intelligence is transforming oncology pharmacy

2024 · Mohammed A. Alnuhait, Alaa N. Shahbar, et al. · Informatics in Medicine Unlocked · 11

The Clinical Safety and Efficacy of Cytarabine and Daunorubicin Liposome ( CPX ‐351) in Acute Myeloid Leukemia Patients: A Systematic Review

2025 · Abdulwahab M. Alzahrani, Mohammed A. Alnuhait, et al. · Cancer Reports · 9

PDF

Ambulatory care hematology/oncology pharmacy services: A comprehensive review by the Saudi Oncology Pharmacy Assembly

2024 · Nada Alsuhebany, Nora Alkhudair, et al. · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 8

PDF

Exploring Entrepreneurship in Pharmacy: Attitudes and Perceptions Among Saudi Pharmacists and Students

2024 · Mohammed Alnuhait, Nada Alqurashi, et al. · Integrated Pharmacy Research and Practice · 7

PDF

Safety and Efficacy of Direct Oral Anticoagulants Apixaban and Rivaroxaban Versus Standard Therapy for VTE Prophylaxis Post Cancer Surgery—A Network Meta-Analysis of Randomized Clinical Trials

2025 · Alaa Shahbar, Abdulaziz Alawlqi, et al. · Journal of Clinical Medicine · 5

Barriers to Rapid Stroke Thrombolysis at a Large Tertiary Care Hospital in Riyadh, Saudi Arabia

2025 · Mohammed Alrashed, Layan Alarifi, et al. · Saudi Journal of Medicine and Medical Sciences · 3

Validation of the HFA-ICOS cardiovascular toxicity risk tool in chronic myeloid leukemia patients receiving tyrosine kinase inhibitors: Real-world data from the Saudi population.

2025 · Nada Alsuhebany, Hamad Alkhalaf, et al. · Journal of Clinical Oncology · 3

Comparison of Three-Bag Method Acetylcysteine Versus Two-Bag Method Acetylcysteine for the Treatment of Acetaminophen Toxicity: An Updated Systematic Review and Meta-Analysis

2024 · Mohammed Alrashed, Abdulrahman Alyousef, et al. · Diseases · 3

PDF

Pharmaceutical Advertising and Public Perceptions in Saudi Arabia

2024 · Mohammed A. Alnuhait, Hana A. Althobaiti, et al. · Pharmacy · 3

Knowledge, Attitude, and Practice Regarding Pharmacovigilance and Barriers to Reporting Adverse Drug Reactions Among the General Population in Saudi Arabia

2024 · Hind Alshehri, Adnan Alharbi, et al. · Risk Management and Healthcare Policy · 3

PDF

Insights into Pharmacists’ Participation in Professional Certification Programs in Saudi Arabia

2024 · Ammar Y. Alhuzli, Mohammed B. Alzahrani, et al. · Healthcare · 3

PDF

Comparative Assessment of Drug Lag for Approved Oncology Targeted Therapies Between Saudi Arabia, the United States, and the European Union

2024 · Mohammed Alnuhait, Abdullah Alshammari, et al. · Therapeutic Innovation & Regulatory Science · 3

Case Series: Sacubitril/Valsartan Role for Chemotherapy-Induced Cardiotoxicity: An in-Depth Investigation in Saudi Arabia

2024 · Abdullah Alshammari, Basmah Qasem, et al. · International Medical Case Reports Journal · 3

PDF

Public awareness in Saudi Arabia toward honey use in infants: A cross sectional study

2024 · Wejdan Alhuthali, Basmah Alsukhayri, et al. · Saudi Journal of Clinical Pharmacy · 3

Assessment of Cardiotoxicity Incidence in Patients Receiving HER-2-Targeted Therapies for Breast Cancer in Saudi Arabia

2024 · Alaa Shahbar, Abdullah A Alhifany, et al. · Clinical Medicine Insights Oncology · 3

Implementing Oncology Pharmacy Boot Camp for Advanced Pharmacy Practice Experience Students at a Regional Conference in Saudi Arabia

2023 · Mohammed Alnuhait, Atika Alharbi, et al. · Cureus · 3

PDF

Awareness and attitudes of oncology specialists toward dihydropyrimidine dehydrogenase testing in Saudi Arabia

2022 · Hatouf H. Sukkarieh, Turki AlSagoor, et al. · Cancer Reports · 3

PDF

Adherence to Hormonal Therapy in Breast Cancer Patients in Saudi Arabia: A Single-Center Study

2022 · Attiah Khobrani, Yasser Alatawi, et al. · Cureus · 3

PDF

Recurrent and Multidrug-Resistant UTI Treatments in Kidney Transplant Patients: A Retrospective Study from Saudi Arabia

2025 · Khalid A. Zahrani, Redwan Y. Mirdad, et al. · Antibiotics · 2

PDF

Works count: 52

Citation count: 222

H-index: 8

I10-index: 7